Home
Longitude Capital Partners V reported a 7.3% stake in CytomX Therapeutics CTMX · 11,538,461 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 7.3%
- Last report
- First report
- Shares held
- 11,538,461 sh
- Class
- Common Stock, $0.00001 par value per share
- Event date
- 25/05/13
- Filed
- 25/05/20
First 5%+ report · 7.3% stake
CytomX Therapeutics trades, last 26 weeks
What else happened in CytomX Therapeutics around then
Filed or reported within 30 days of the trade day · 25/04/13~25/06/12Longitude Capital Partners V's other 5% stake reports
- Longitude Capital Partners V
5% stakeEntera Bio
5% stakeEntera Bio
ENTX
4.6% stake
7,843,138 sh
4.6% stake
Filed 08/04
- Longitude Capital Partners V
5% stakeMobia Medical
5% stakeMobia Medical
MOBI
9.8% stake
3,255,226 sh
9.8% stake
Filed 05/13
- Longitude Capital Partners V
5% stakeVeradermics
5% stakeVeradermics
MANE
11.3% stake
4,653,873 sh
11.3% stake
Filed 05/05
- Longitude Capital Partners V
5% stakeVeradermics
5% stakeVeradermics
MANE
12.5% stake
4,653,873 sh
12.5% stake
Filed 02/12
